Mirae Asset Global Investments Co., Ltd. Nuvalent, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Nuvalent, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,187 shares of NUVL stock, worth $187,382. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,187
Previous 2,147
1.86%
Holding current value
$187,382
Previous $219,000
21.92%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding NUVL
# of Institutions
216Shares Held
59.6MCall Options Held
450KPut Options Held
619K-
Deerfield Management Company, L.P. (Series C) New York, NY20MShares$1.71 Billion38.02% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5MShares$428 Million18.43% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.13MShares$354 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$259 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.98MShares$255 Million7.96% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.68B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...